GSA Capital Partners’s Sanofi SNY Stock Holding History

GSA Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,222	Closed	-$205K	–	2134
2025 Q4	$205K	Buy	+4,222	New	+$209K	0.02%	1401

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GSA Capital Partners's SNY Position: Q1 2026 in Review

GSA Capital Partners sold out of Sanofi (SNY) in Q1 2026, closing a stake of 4,222 shares — an estimated $205K sold.

GSA Capital Partners first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $205K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

GSA Capital Partners reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
GSA Capital Partners sold 4,222 Sanofi shares in Q1 2026, an estimated $205K.
GSA Capital Partners first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
GSA Capital Partners's Sanofi position peaked at $205K in Q4 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.